INTRODUCTION
Pre eclampsia is associated with an enhanced burden of severe obstetric morbidity. Worldwide, the incidence of preeclampsia ranges between 2% and 10% of pregnancies. WHO estimates the incidence of preeclampsia to be seven times higher in developing countries (2.8% of live births) than in developed countries (0.4%). 1 various risk factors and preventive measures for pre eclampsia have been tested, still there are no definitive preventive measures.
The current hypothesis regarding the aetiology of preeclampsia is focused on mal adaptation of immune responses and defective trophoblastic invasion. Thus, an excessive maternal inflammatory response, perhaps directed against foreign foetal antigens, results in a chain of events including shallow trophoblastic invasion, defective spiral artery remodelling, placental infarction and release of pro-inflammatory cytokines and placental fragments in the systemic circulation. 2 Maternal immune rejection of the placental cytotrophoblastic invasion of spiral arteries leads to shallow implantation and hypoxia Department of Obstetrics and Gynaecology, B.R.D Medical College, Gorakhpur, Uttar Pradesh, India and release of inflammatory mediators. With the recognition of immune modulator properties of vitamin D it has been the subject of recent research. Vitamin D receptors and 1-α hydroxylase are expressed both in decidua and trophoblastic cells. 3, 4 providing an evidence for role of vitamin D in placentation. Evidence also exist that vitamin D is able to regulate key target genes associated with implantation of the embryo, trophoblastic invasion and implantation tolerance. 3 High incidence of vitamin D deficiency in early pregnancy is found in a tropical country like India which has abundant sunlight for most of the year. This paradox can be explained due to many prevalent social and cultural practices i.e. increased urbanization, poor outdoor activity, greater pollution that preclude exposure of women to sunlight coupled with skin pigment melanin which absorbs ultraviolet B photons and reduces vitamin D synthesis by greater than 90%. Since pre eclampsia contributes to 9% of maternal deaths in Asia 5 finding relation with vitamin D may lead us to a non-expensive measure to possibly prevent it. This would have widespread maternal health implication, as so far we do not have definitive preventive measures. So this study was conducted to study the association of vitamin D deficiency with pre eclampsia.
METHODS
We conducted a quantitative cross sectional study for a period of one year from August 2014 to July 2015. Patients who were included in this study had to provide consent for the collection of demographic and outcome data and venipuncture for collection of plasma to be used in 25-OH-D analysis. Cases were recruited from the inpatient Labour and Delivery unit at the Obstetrics and Gynaecology department BRD Medical College Gorakhpur, after confirmation of the diagnosis of pre eclampsia. Equal numbers of normotensive pregnant females were also taken. Pre eclamptic cases had to meet the American College of Obstetrics and Gynaecology criteria for diagnosing pre eclampsia. Patients with chronic hypertension, gestational diabetes mellitus, renal disease, liver disease, autoimmune disorders, or multi fetal gestation were excluded. A total of 384 admitted pregnant women were enrolled which were further categorized into two equal, pre eclamptic and non pre eclamptic groups. Detailed data were collected via inperson interviews. Pre-designed and pre-tested questionnaires administered to the targeted participants and information was collected. The demographic age was self-reported, and was recorded as a whole number in years at the time of screening. Age was then classified into the following four categories: <20 years, 21-30 years, 31-40 years and >40 years. Religion was selfreported. It was categorized into the following groups Hindus, Muslims and others. Parity, family history preexisting medical conditions, gestational age, education, socioeconomic status, prenatal vitamin D use, smoking status, intake of Vitamin D rich products and sun exposure habits were enquired. Fasting blood samples were drawn from the enrolled patients. Vitamin D concentration was determined by the concentration of 25-OH vitamin D in ng/ml (normal range 20 to 100 ng/ml [6] [7] [8] ) in the serum of participants. 25-OH vitamin D concentration of <20 ng/ml was considered as deficient, while concentrations of ≥20 ng/ml and above was considered as sufficient. Because there is no universally acceptable definition of vitamin D deficiency, we used cut off points suggested recently by some studies. 23 ,24,26 Serum samples were drawn at similar gestational ages in both the groups.
Measurement of vitamin D
Statistical analyses were performed and data summarized using basic descriptive statistics. We performed the unadjusted analyses chi square tests to compare and observe differences between pre eclamptic and non pre eclamptic groups. All P values were two-tailed, with P<0.05 considered statistically significant.
RESULTS
All the selected patients were matched in terms of age, parity, religion, gestational age, socioeconomic status, and education i.e. the number of patients falling in both the groups was almost the same.
Majority of the patients in both pre eclamptic (82.29%) and non pre eclamptic groups (66.14%) were not taking vitamin D supplements. Among pre eclamptic only 36.45% patients were exposed to sunlight for >1/2 hours a day. Rest of them (63.5%) receive sunlight for <1/2 hours a day. Among non pre eclamptic 56.25% were exposed for >1/2 hours and only 43.75% for <1/2 hours (Table 1) .
About 82.8% of pre eclamptic and 31.25% of non pre eclamptic patients were found deficient in vitamin D. Vitamin D levels were sufficient in 17.2% of pre eclamptic and 68.75% of non pre eclamptic patients ( Table 2) . Majority of primi gravida patients in both the groups were deficient in vitamin D. It was also found that majority of severe pre eclamptic patients (51.78%) had very low (<10 ng/ml) vitamin D concentration (Table 3) . Consistent with previous studies, this study also found lower maternal 25OH vitamin D serum levels in pre eclamptic than in non pre eclamptic patients. This is comparable to a nested case control study by Bodnar et al. 8 25-hydroxyvitamin D was measured in banked serum.The 25 hydroxy vitamin D concentrations in early pregnancy were significantly lower in 55 women who developed pre eclampsia later in pregnancy than in 219 women who did not develop pre eclampsia.
There are other studies with similar results.
9-15 Almost similar study done by Robinson in 2010 in which patients with early onset severe pre eclampsia had significantly decreased (p value<0.001) levels of 25-OH-D relative to healthy control pregnancies. 15 However, some studies have not supported the association between vitamin D and pre eclampsia. Shand and Nassar reported no significant association between adverse pregnancy outcomes and serum 25OHD concentration levels. 16 Levels of total and free 25(OH) vitamin D in first trimester was not found to be associated with either first trimester blood pressure or development of subsequent pre eclampsia in a study done by Powe et al. 17 Also Wetta et al., in their case control study, demonstrated that serum 25(OH) vitamin D levels measured at the 15 th and 21 st week of pregnancy, in the two groups were similar. 18 A meta-analysis done to assess the association between maternal serum vitamin D levels and risk of pre eclampsia included 15 articles and 8 studies. They concluded that the overall effect was significant for studies that defined vitamin D deficiency as 25(OH) D≤50 nmol/L (20 ng/ml), but not for those which considered it as <38 nmol/L (15.2 ng/ml).
In a relatively large prospective study performed in Norway by Haugen et al., the risk of pre eclampsia was found to be decreased by 27% in patients who received vitamin D in a dose of 400-600 IU/ daily through supplemental treatment. 20 However in a Randomised Controlled Trial conducted by Marya et al., no significant difference was found in the incidence of preeclampsia between cases with or without vitamin D supplementation (1,200 IU/daily) during the 20 th and 24 th week of pregnancy in 400 patients. 21 In the present study among pre eclamptic patients most (63.5%) were inadequately exposed to sunlight as compared to non pre eclamptic patients among whom 43.75% received inadequate exposure. This is comparable to a study done by Magnus and Eskild where mothers of children born in summer had the lowest risk of pre eclampsia, and the risk was highest in the winter months. 22 In the present study vitamin D deficiency was found in majority of patients (82.8%) with pre eclampsia, suggesting that maternal 25(OH) vitamin D deficiency in pregnancy is associated with an increased risk of pre eclampsia. This is similar to study done by Baker et al who found that mid gestation maternal 25(OH) vitamin D concentration was lower in women who subsequently developed severe preeclampsia compared with controls. 23 In a case-cohort study it was found that maternal vitamin D deficiency may be a risk factor for severe pre eclampsia, but it is not associated with pre eclampsia overall or its mild subtypes. 9 No significant difference was found in vitamin D status among both mild and severe subtypes of pre eclampsia. Overall the level of supplementation was very low, in both the groups probably because of high level of illiteracy and maximum number of patient belonging to lower socioeconomic class.
Regarding sun exposure habits it was found that most of the pre eclamptic patients were inadequately exposed to sunlight.
In light of previous findings of a positive association between low vitamin D status and pre eclampsia and the biological plausibility of the association. This finding needs to be tested in a larger sample size. In addition studies focusing on women in eastern U.P. alone should be carried out to determine the true nature of the association between low vitamin D status and disparity of pre eclampsia rates in this population. Such an approach would diffuse the effects to a vastly heterogeneous population.
